Financials

  • Market Capitalization 1.75 B
  • Employee 130
  • Founded 2019
  • CEO N/A
  • Website www.septerna.com
  • Headquarter Delaware, United States
  • FIGI BBG014WY1V28
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-25.35
Rapporto prezzo/fatturato
26.85

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2029
BHVN
Biohaven Ltd. Common Shares
11.80 USD-2.40%-9.23%-6.35%-30.35%1.78 B USD
2037
NTLA
Intellia Therapeutics, Inc. - Common Stock
12.58 USD-3.75%+0.64%+7.89%-8.31%1.76 B USD
2048
ZBIO
Zenas BioPharma, Inc. - Common Stock
26.40 USD-3.15%-5.27%-14.84%-0.23%1.72 B USD
2049
NUVB
Nuvation Bio Inc. Class A Common Stock
4.90 USD-2.00%-1.01%-16.95%+34.25%1.72 B USD